Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues

Inhibition of angiogenesis is currently perceived as one of the promising strategies in the treatment of cancer. The antiangiogenic property of thalidomide has inspired a second wave of research on this teratogenic drug. Previous studies from our group and others demonstrated that metabolites of tha...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer research (Chicago, Ill.) Ill.), 2003-06, Vol.63 (12), p.3189-3194
Hauptverfasser:	NG, Sylvia S. W, GÜTSCHOW, Michael, WEISS, Michael, HAUSCHILDT, Sunna, TEUBERT, Uwe, HECKER, Thomas K, LUZZIO, Frederick A, KRUGER, Erwin A, EGER, Kurt, FIGG, William D
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - pathology Androgens Angiogenesis Inhibitors - pharmacology Animals Antineoplastic agents Aorta - drug effects Biological and medical sciences Cell Division - drug effects Chemotherapy Drug Screening Assays, Antitumor Endothelium, Vascular - cytology Endothelium, Vascular - drug effects Humans Male Medical sciences Molecular Structure Neoplasms, Hormone-Dependent - pathology Neovascularization, Physiologic - drug effects Organ Culture Techniques Pharmacology. Drug treatments Prostatic Neoplasms - pathology Rats Structure-Activity Relationship Thalidomide - analogs & derivatives Thalidomide - pharmacology Tumor Cells, Cultured - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!